Skip to main content
logo
RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9700
-0.0400 (-3.96%)
At close: Apr 1, 2026, 4:00 PM EDT
1.000
+0.030 (3.09%)
After-hours: Apr 1, 2026, 4:38 PM EDT

RenovoRx Revenue

In the year 2025, RenovoRx had annual revenue of $1.12M with 2,511.63% growth. RenovoRx had revenue of $238.00K in the quarter ending December 31, 2025, with 453.49% growth.

Revenue (ttm)
$1.12M
Revenue Growth
+2,511.63%
P/S Ratio
39.51
Revenue / Employee
$112,300
Employees
10
Market Cap
43.74M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.12M1.08M2,511.63%
Dec 31, 202443.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xilio Therapeutics43.77M
Metagenomi Therapeutics25.21M
MindWalk Holdings20.70M
Radiopharm Theranostics10.86M
Immutep5.28M
Mereo BioPharma Group500.00K
Lisata Therapeutics170.00K
Entera Bio42.00K
Revenue Rankings

RNXT News

More News